Search results
Results From The WOW.Com Content Network
The COVID-19 pandemic in Turkey is part of the ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in Turkey was recorded on 11 March, when a local returned home [ note 1 ] from a trip to Europe. [ 4 ]
Dozens of captive animal species have been found infected or proven able to be experimentally infected with SARS-CoV-2, the virus that causes COVID-19. The virus has also been found in over a dozen wild animal species. Most animal species that can get the virus have not been proven to be able to spread it back to humans.
SARS-CoV-2 is the seventh known coronavirus to infect people, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV. [105] Like the SARS-related coronavirus implicated in the 2003 SARS outbreak, SARS‑CoV‑2 is a member of the subgenus Sarbecovirus (beta-CoV lineage B). [106] [107] Coronaviruses undergo frequent recombination. [108]
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]
In March 2022, the BBC wrote, "There are now many drugs that target the virus or our body in different ways: anti-inflammatory drugs that stop our immune system overreacting with deadly consequences, anti-viral drugs that make it harder for the coronavirus to replicate inside the body and antibody therapies that mimic our own immune system to ...
The COVID-19 vaccination campaign in Turkey began on January 14, 2021. [2] As of April 2nd, 2022, 57,784,362 people have received their first dose, and 52,982,877 people have been fully vaccinated. [1] 27,648,857 people received their third dose. [1] 63% of the total population in Turkey is fully vaccinated.
For premium support please call: 800-290-4726 more ways to reach us
Pharmaceutical compound Turkovac Vaccine description Target SARS-CoV-2 Vaccine type Inactivated Clinical data Other names Erucov-Vac Routes of administration Intramuscular Legal status Legal status Full list of Turkovac authorizations Identifiers CAS Number 2695585-27-2 Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each ...